Philips Reports Strong European Sales Amid Quarterly Revenue Dip

Deep News05-06 15:40

Royal Philips NV's healthcare technology group saw a decline in nominal sales for the first quarter, despite strong growth in Western European markets.

The Dutch company posted first-quarter revenue of €3.91 billion (equivalent to $4.57 billion), compared with €4.1 billion in the same period last year. According to consensus analyst estimates, market expectations had been for first-quarter sales of €3.88 billion.

On a comparable basis, however, sales increased by 4% year-on-year. The company attributed the growth in comparable sales to improved performance in North America, across European markets, and in the personal health business segment. Sales in Europe rose under both nominal and comparable measures.

Net profit for the first quarter of 2026 was €151 million, up from €76 million in the prior-year period. Analysts had expected net profit of €66 million.

Royal Philips maintained its full-year outlook, projecting an adjusted EBITA margin between 12.5% and 13.0%. The company also expects full-year comparable sales growth in the range of 3% to 4.5%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1135255520?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-06 15:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1135255520","market":"sg","top_or_hot":-1,"title":"Philips Reports Strong European Sales Amid Quarterly Revenue Dip","media":"Deep News","content":"<p>Royal Philips NV's healthcare technology group saw a decline in nominal sales for the first quarter, despite strong growth in Western European markets.</p>\n<p>The Dutch company posted first-quarter revenue of €3.91 billion (equivalent to $4.57 billion), compared with €4.1 billion in the same period last year. According to consensus analyst estimates, market expectations had been for first-quarter sales of €3.88 billion.</p>\n<p>On a comparable basis, however, sales increased by 4% year-on-year. The company attributed the growth in comparable sales to improved performance in North America, across European markets, and in the personal health business segment. Sales in Europe rose under both nominal and comparable measures.</p>\n<p>Net profit for the first quarter of 2026 was €151 million, up from €76 million in the prior-year period. Analysts had expected net profit of €66 million.</p>\n<p>Royal Philips maintained its full-year outlook, projecting an adjusted EBITA margin between 12.5% and 13.0%. The company also expects full-year comparable sales growth in the range of 3% to 4.5%.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Philips Reports Strong European Sales Amid Quarterly Revenue Dip</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPhilips Reports Strong European Sales Amid Quarterly Revenue Dip\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2026-05-06 15:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Royal Philips NV's healthcare technology group saw a decline in nominal sales for the first quarter, despite strong growth in Western European markets.</p>\n<p>The Dutch company posted first-quarter revenue of €3.91 billion (equivalent to $4.57 billion), compared with €4.1 billion in the same period last year. According to consensus analyst estimates, market expectations had been for first-quarter sales of €3.88 billion.</p>\n<p>On a comparable basis, however, sales increased by 4% year-on-year. The company attributed the growth in comparable sales to improved performance in North America, across European markets, and in the personal health business segment. Sales in Europe rose under both nominal and comparable measures.</p>\n<p>Net profit for the first quarter of 2026 was €151 million, up from €76 million in the prior-year period. Analysts had expected net profit of €66 million.</p>\n<p>Royal Philips maintained its full-year outlook, projecting an adjusted EBITA margin between 12.5% and 13.0%. The company also expects full-year comparable sales growth in the range of 3% to 4.5%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"","article_id":"1135255520","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1135255520","pubTimestamp":1778053241,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"Royal Philips NV's healthcare technology group saw a decline in nominal sales for the first quarter, despite strong growth in Western European markets. The Dutch company posted first-quarter revenue...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","EURL":"Direxion Daily FTSE Europe Bull 3X Shares","BK4082":"医疗保健设备","PHG":"飞利浦","IEUR":"安硕核心MSCI欧洲ETF","BK4588":"碎股"},"translate_title":"飞利浦报告在季度收入下降的情况下欧洲销售强劲","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IEUR":1,"EURL":1,"PHG":1},"content_text":"Royal Philips NV's healthcare technology group saw a decline in nominal sales for the first quarter, despite strong growth in Western European markets.\nThe Dutch company posted first-quarter revenue of €3.91 billion (equivalent to $4.57 billion), compared with €4.1 billion in the same period last year. According to consensus analyst estimates, market expectations had been for first-quarter sales of €3.88 billion.\nOn a comparable basis, however, sales increased by 4% year-on-year. The company attributed the growth in comparable sales to improved performance in North America, across European markets, and in the personal health business segment. Sales in Europe rose under both nominal and comparable measures.\nNet profit for the first quarter of 2026 was €151 million, up from €76 million in the prior-year period. Analysts had expected net profit of €66 million.\nRoyal Philips maintained its full-year outlook, projecting an adjusted EBITA margin between 12.5% and 13.0%. The company also expects full-year comparable sales growth in the range of 3% to 4.5%.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1135255520","isCrawlerRequest":true}